These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
345 related items for PubMed ID: 21298332
21. Early Alzheimer's disease neuropathology detected by proton MR spectroscopy. Murray ME, Przybelski SA, Lesnick TG, Liesinger AM, Spychalla A, Zhang B, Gunter JL, Parisi JE, Boeve BF, Knopman DS, Petersen RC, Jack CR, Dickson DW, Kantarci K. J Neurosci; 2014 Dec 03; 34(49):16247-55. PubMed ID: 25471565 [Abstract] [Full Text] [Related]
22. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study. Kantarci K, Jack CR, Xu YC, Campeau NG, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Kokmen E, Tangalos EG, Petersen RC. Neurology; 2000 Jul 25; 55(2):210-7. PubMed ID: 10908893 [Abstract] [Full Text] [Related]
23. A Critical Proton MR Spectroscopy Marker of Alzheimer's Disease Early Neurodegenerative Change: Low Hippocampal NAA/Cr Ratio Impacts APOE ɛ4 Mexico City Children and Their Parents. Calderón-Garcidueñas L, Mora-Tiscareño A, Melo-Sánchez G, Rodríguez-Díaz J, Torres-Jardón R, Styner M, Mukherjee PS, Lin W, Jewells V. J Alzheimers Dis; 2015 Jul 25; 48(4):1065-75. PubMed ID: 26402110 [Abstract] [Full Text] [Related]
24. Hippocampal metabolites and memory performances in patients with amnestic mild cognitive impairment and Alzheimer's disease. Watanabe T, Shiino A, Akiguchi I. Neurobiol Learn Mem; 2012 Mar 25; 97(3):289-93. PubMed ID: 22390859 [Abstract] [Full Text] [Related]
25. Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging. Zhu X, Schuff N, Kornak J, Soher B, Yaffe K, Kramer JH, Ezekiel F, Miller BL, Jagust WJ, Weiner MW. Alzheimer Dis Assoc Disord; 2006 Mar 25; 20(2):77-85. PubMed ID: 16772742 [Abstract] [Full Text] [Related]
26. Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study. Huang W, Alexander GE, Chang L, Shetty HU, Krasuski JS, Rapoport SI, Schapiro MB. Neurology; 2001 Aug 28; 57(4):626-32. PubMed ID: 11524470 [Abstract] [Full Text] [Related]
27. N-acetylaspartate, choline, myoinositol, glutamine and glutamate (glx) concentration changes in proton MR spectroscopy (1H MRS) in patients with mild cognitive impairment (MCI). Walecki J, Barcikowska M, Ćwikła JB, Gabryelewicz T. Med Sci Monit; 2011 Dec 28; 17(12):MT105-11. PubMed ID: 22129910 [Abstract] [Full Text] [Related]
28. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy. Pilatus U, Lais C, Rochmont Adu M, Kratzsch T, Frölich L, Maurer K, Zanella FE, Lanfermann H, Pantel J. Psychiatry Res; 2009 Jul 15; 173(1):1-7. PubMed ID: 19427767 [Abstract] [Full Text] [Related]
29. Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy. Metastasio A, Rinaldi P, Tarducci R, Mariani E, Feliziani FT, Cherubini A, Pelliccioli GP, Gobbi G, Senin U, Mecocci P. Neurobiol Aging; 2006 Jul 15; 27(7):926-32. PubMed ID: 15936850 [Abstract] [Full Text] [Related]
30. Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis. Wang H, Tan L, Wang HF, Liu Y, Yin RH, Wang WY, Chang XL, Jiang T, Yu JT. J Alzheimers Dis; 2015 Jul 15; 46(4):1049-70. PubMed ID: 26402632 [Abstract] [Full Text] [Related]
31. Age-related changes in brain metabolites and cognitive function in APP/PS1 transgenic mice. Chen SQ, Cai Q, Shen YY, Wang PJ, Teng GJ, Zhang W, Zang FC. Behav Brain Res; 2012 Nov 01; 235(1):1-6. PubMed ID: 22828014 [Abstract] [Full Text] [Related]
32. Whole-brain patterns of (1)H-magnetic resonance spectroscopy imaging in Alzheimer's disease and dementia with Lewy bodies. Su L, Blamire AM, Watson R, He J, Hayes L, O'Brien JT. Transl Psychiatry; 2016 Aug 30; 6(8):e877. PubMed ID: 27576166 [Abstract] [Full Text] [Related]
34. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging. MacKay S, Meyerhoff DJ, Constans JM, Norman D, Fein G, Weiner MW. Arch Neurol; 1996 Feb 30; 53(2):167-74. PubMed ID: 8639067 [Abstract] [Full Text] [Related]
35. Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study. Schuff N, Amend D, Ezekiel F, Steinman SK, Tanabe J, Norman D, Jagust W, Kramer JH, Mastrianni JA, Fein G, Weiner MW. Neurology; 1997 Dec 30; 49(6):1513-21. PubMed ID: 9409338 [Abstract] [Full Text] [Related]
36. [Proton spectroscopy in Alzheimer's disease and cognitive impairment not dementia: a community study]. Azevedo D, Bottino CM, Tatsch M, Hototian SR, Bazzarella MC, Castro CC. Arq Neuropsiquiatr; 2005 Dec 30; 63(4):1021-7. PubMed ID: 16400423 [Abstract] [Full Text] [Related]
37. An 1H-MRS framework predicts the onset of Alzheimer's disease symptoms in PSEN1 mutation carriers. Londono AC, Castellanos FX, Arbelaez A, Ruiz A, Aguirre-Acevedo DC, Richardson AM, Easteal S, Lidbury BA, Arcos-Burgos M, Lopera F. Alzheimers Dement; 2014 Sep 30; 10(5):552-61. PubMed ID: 24239247 [Abstract] [Full Text] [Related]